BIOPHARMACEUTICAL developer Bone Medical has received clearance to commence human clinical trials of its oral parathyroid hormone BN003.Results from those trials, which are due to start in February, are expected in the second quarter of 2005.
08/02/2005 - 21:00
Bone enters human clinical trials
08/02/2005 - 21:00
